ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Trifluoroacetohydrazide → (S)-8-Benzyl-9-((2-(trifluoromethoxy)phenyl)sulfonyl)-3-(trifluoromethyl)-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[4,3-a][1,4]diazocine

HRID 1429414
印刷

反応式

HRID 1429414 の反応式
[CH2:1]([C@@H:8]1[CH2:15][CH2:14][CH2:13][NH:12][C:11](=S)[CH2:10][N:9]1[S:17]([C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][C:21]=1[O:26][C:27]([F:30])([F:29])[F:28])(=[O:19])=[O:18])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[C:31]([C:35]([NH:37][NH2:38])=O)([F:34])([F:33])[F:32].CC1C=CC(S(O)(=O)=O)=CC=1.O>C1COCC1.CCOCC.C1(C)C=CC=CC=1.O.CC(=O)OCC.[Hg](OC(C)=O)OC(C)=O>[CH2:1]([C@@H:8]1[CH2:15][CH2:14][CH2:13][N:12]2[C:35]([C:31]([F:34])([F:33])[F:32])=[N:37][N:38]=[C:11]2[CH2:10][N:9]1[S:17]([C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][C:21]=1[O:26][C:27]([F:30])([F:29])[F:28])(=[O:19])=[O:18])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

9

反応物 3

HCID 229753TrifluoroacetohydrazideHCID 521998p-Toluenesulfonic acid monohydrateHCID 86677168(S)-5-Benzyl-4-((2-(trifluoromethoxy)phenyl)sulfonyl)-1,4-diazocane-2-thione

生成物 1

HCID 89414355(S)-8-Benzyl-9-((2-(trifluoromethoxy)phenyl)sulfonyl)-3-(trifluoromethyl)-5,6,7,8,9,10-hexahydro-[1,2,4]triazolo[4,3-a][1,4]diazocine収率 64.1%

試薬・触媒・溶媒 5

HCID 16683746
Diacetyloxymercury
触媒
HCID 3283Diethyl Ether溶媒
HCID 8028Tetrahydrofuran溶媒
HCID 8857Ethyl Acetate溶媒
HCID 22272177Toluene water溶媒

実験手順

A solution of compound 31n (150 mg, 0.33 mmol) in THF (15 mL) was cooled to 0° C., treated with Hg(OAc)2 (118 mg, 0.36 mmol) and CF3CONHNH2 (173 mg, 1.65 mmol), stirred for 2 h, diluted with Et2O (20 mL), filtered through Celite and evaporated. A solution of the residue in toluene/H2O (30:1, 15 mL) was treated with TsOH.H2O (250 mg, 1.32 mmol) and stirred at 75° C. for 12 h. The mixture was diluted with EA (30 mL) and washed with saturated K2CO3. The aqueous layer was extracted with EA (20 mL). The combined organic layers were dried over Na2SO4. After filtration, the filtrate was evaporated and the residue was purified by Preparative HPLC to give compound 31 as a white solid (113 mg, 64% yield). 1H NMR (500 MHz, CDCl3) δ 8.14 (d, J=7.5 Hz, 1H), 7.68 (t, J=8.5 Hz, 1H), 7.50 (t, J=7.5 Hz, 1H), 7.40 (d, J=8.5 Hz, 1H), 7.15-7.10 (m, 3H), 6.76-6.70 (m, 2H), 5.71 (d, J=18.0 Hz, 1H), 4.97 (m, 1H), 4.90 (d, J=8.0 Hz, 1H), 4.26 (dd, J=15.0, 8.0 Hz, 1H) 4.21 (m, 1H), 2.59 (dd, J=13.0, 10.5 Hz, 1H), 2.33 (dd, J=13.0, 5.0 Hz, 1H), 2.12-1.90 (m, 2H), 1.70-1.60 (m, 2H). MS (ESI+) m/z: 535 [M+H]+.

後処理

  1. filtrationfiltered through Celite
  2. customevaporated
  3. stirringstirred at 75° C. for 12 h
  4. washwashed with saturated K2CO3
  5. extractionThe aqueous layer was extracted with EA (20 mL)
  6. dry with materialThe combined organic layers were dried over Na2SO4
  7. filtrationAfter filtration
  8. customthe filtrate was evaporated
  9. customthe residue was purified by Preparative HPLC

出典と根拠

ORDレコード
ord-d5a9a8fe80694e6486480c3ba25ea9e2
出典データセット
uspto-grants-2015_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08940722B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート